Top Performing Drug of 2021 - Trulicity (February Edition)
PharmaShots
FEBRUARY 22, 2023
In the US, Trulicity is protected by a compound patent (2027) and by biologics data protection (2026).
2027 Communication Compounding 
64 
High biologics demand spurs need for greater contract manufacturing
Pharmaceutical Technology
APRIL 24, 2023
Meanwhile, the Indian biologics market is expected to grow to $12 billion by 2025, with a compound annual growth rate (CAGR) of 22%. GlobalData forecasts Biologics to significantly overtake sales of small molecules by $120 billion by 2027. Please check your email to download the Whitepaper.
Empress Therapeutics emerges with $50m to fund small molecule development
Pharmaceutical Technology
JUNE 21, 2023
Dr. Doug Cole, co-founder of Empress Therapeutics, explained that Chemilogics links gene pathways to small molecule compounds, allowing for drugs with the versatility of small molecules without the unpredictable, expensive, and time-consuming discovery process. Murray KcKinnon, PhD He joined Empress as chief scientific officer.
Let's personalize your content